Enzymatica’s shares were admitted for trading on Nasdaq First North Growth Market on June 15, 2015.
The number of shares is 142,823,696. Closing price on December 30, 2019 was SEK 3.97, corresponding to a market capitalization of approximately SEK 567 million. In 2019, average turnover per trading day was approximately 100,703 shares, equivalent to approximately SEK 310,000. During 2019 the share price increased by 80 percent, from SEK 2.20 to SEK 3.97.
ISIN code: SE0003943620
Sector: Health care
First North Growth Market is an alternative market, operated by the various exchanges within Nasdaq. It does not have the same legal status as a regulated market. Companies on First North Growth Market are subject to the rules of First North Growth Market and not the legal requirements for admission to trading on a regulated market. An investment in a company traded on First North Growth Market is riskier than an investment in a listed company.